vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and MESABI TRUST (MSB). Click either name above to swap in a different company.

Alector, Inc. is the larger business by last-quarter revenue ($6.2M vs $3.6M, roughly 1.7× MESABI TRUST). On growth, Alector, Inc. posted the faster year-over-year revenue change (-88.5% vs -95.5%). Over the past eight quarters, MESABI TRUST's revenue compounded faster (-24.1% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

Mesabi Trust is a United States-based royalty trust that holds permanent royalty interests in iron ore mining properties located in Minnesota's Mesabi Range. It earns revenue primarily from royalty payments tied to the production and sale of iron ore products, with core earnings sourced from active mining partners operating on the land it holds interests in, catering to the global steel manufacturing market.

ALEC vs MSB — Head-to-Head

Bigger by revenue
ALEC
ALEC
1.7× larger
ALEC
$6.2M
$3.6M
MSB
Growing faster (revenue YoY)
ALEC
ALEC
+7.0% gap
ALEC
-88.5%
-95.5%
MSB
Faster 2-yr revenue CAGR
MSB
MSB
Annualised
MSB
-24.1%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ALEC
ALEC
MSB
MSB
Revenue
$6.2M
$3.6M
Net Profit
$2.8M
Gross Margin
77.1%
Operating Margin
Net Margin
77.1%
Revenue YoY
-88.5%
-95.5%
Net Profit YoY
-1696.9%
-96.5%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
MSB
MSB
Q4 25
$6.2M
$3.6M
Q3 25
$3.3M
$5.6M
Q2 25
$7.9M
$4.7M
Q1 25
$3.7M
$6.9M
Q4 24
$54.2M
$79.0M
Q3 24
$15.3M
$6.5M
Q2 24
$15.1M
$6.3M
Q1 24
$15.9M
$6.2M
Net Profit
ALEC
ALEC
MSB
MSB
Q4 25
$2.8M
Q3 25
$-34.7M
$4.7M
Q2 25
$-30.5M
$3.6M
Q1 25
$-40.5M
$6.1M
Q4 24
$-2.1M
$78.3M
Q3 24
$-42.2M
$5.4M
Q2 24
$-38.7M
$3.5M
Q1 24
$-36.1M
$4.7M
Gross Margin
ALEC
ALEC
MSB
MSB
Q4 25
77.1%
Q3 25
84.6%
Q2 25
76.7%
Q1 25
88.5%
Q4 24
99.1%
Q3 24
83.2%
Q2 24
55.7%
Q1 24
75.3%
Operating Margin
ALEC
ALEC
MSB
MSB
Q4 25
Q3 25
-1153.6%
Q2 25
-433.6%
Q1 25
-1216.5%
Q4 24
-13.4%
Q3 24
-315.7%
Q2 24
-302.4%
Q1 24
-275.0%
Net Margin
ALEC
ALEC
MSB
MSB
Q4 25
77.1%
Q3 25
-1063.4%
84.6%
Q2 25
-387.7%
76.7%
Q1 25
-1101.6%
88.5%
Q4 24
-3.8%
99.1%
Q3 24
-275.2%
83.2%
Q2 24
-256.4%
55.7%
Q1 24
-227.0%
75.3%
EPS (diluted)
ALEC
ALEC
MSB
MSB
Q4 25
Q3 25
$-0.34
Q2 25
$-0.30
Q1 25
$-0.41
Q4 24
$-0.02
Q3 24
$-0.43
Q2 24
$-0.40
Q1 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
MSB
MSB
Cash + ST InvestmentsLiquidity on hand
$256.0M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$21.1M
Total Assets
$293.2M
$26.0M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
MSB
MSB
Q4 25
$256.0M
Q3 25
$291.1M
Q2 25
$307.3M
Q1 25
$354.6M
Q4 24
$413.4M
Q3 24
$457.2M
Q2 24
$503.3M
Q1 24
$562.1M
Total Debt
ALEC
ALEC
MSB
MSB
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
MSB
MSB
Q4 25
$30.6M
$21.1M
Q3 25
$57.7M
$22.8M
Q2 25
$71.2M
$19.6M
Q1 25
$94.6M
$23.3M
Q4 24
$126.8M
$95.3M
Q3 24
$118.9M
$22.1M
Q2 24
$150.6M
$20.7M
Q1 24
$178.9M
$21.0M
Total Assets
ALEC
ALEC
MSB
MSB
Q4 25
$293.2M
$26.0M
Q3 25
$335.3M
$24.8M
Q2 25
$356.4M
$27.4M
Q1 25
$408.3M
$101.7M
Q4 24
$468.3M
$100.7M
Q3 24
$516.0M
$26.2M
Q2 24
$570.7M
$25.1M
Q1 24
$635.5M
$26.7M
Debt / Equity
ALEC
ALEC
MSB
MSB
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
MSB
MSB
Operating Cash FlowLast quarter
$-184.0M
$3.5M
Free Cash FlowOCF − Capex
$-184.1M
FCF MarginFCF / Revenue
-2951.3%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$-326.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
MSB
MSB
Q4 25
$-184.0M
$3.5M
Q3 25
$-32.5M
$4.4M
Q2 25
$-49.0M
$2.1M
Q1 25
$-60.8M
$93.9M
Q4 24
$-55.0M
$78.2M
Q3 24
$-50.7M
$3.8M
Q2 24
$-62.8M
$2.5M
Q1 24
$-61.3M
$14.6M
Free Cash Flow
ALEC
ALEC
MSB
MSB
Q4 25
$-184.1M
Q3 25
$-32.5M
Q2 25
$-49.1M
Q1 25
$-60.8M
Q4 24
$-55.2M
Q3 24
$-50.9M
Q2 24
$-63.1M
Q1 24
$-61.9M
FCF Margin
ALEC
ALEC
MSB
MSB
Q4 25
-2951.3%
Q3 25
-997.6%
Q2 25
-623.0%
Q1 25
-1655.0%
Q4 24
-101.8%
Q3 24
-332.1%
Q2 24
-418.6%
Q1 24
-389.3%
Capex Intensity
ALEC
ALEC
MSB
MSB
Q4 25
0.7%
Q3 25
0.3%
Q2 25
0.1%
Q1 25
0.5%
Q4 24
0.3%
Q3 24
1.4%
Q2 24
2.2%
Q1 24
3.4%
Cash Conversion
ALEC
ALEC
MSB
MSB
Q4 25
1.27×
Q3 25
0.92×
Q2 25
0.57×
Q1 25
15.48×
Q4 24
1.00×
Q3 24
0.71×
Q2 24
0.72×
Q1 24
3.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons